Ron Piervincenzi, Ph.D., CEO of United States Pharmacopeia, sits down with host, Rich Bendis, to discuss USP’s growth since his last visit, the nature of their organization, and plans on hosting the 2022 BioHealth Capital Region Forum in person at their beautiful building in Rockville, Maryland.
EIRs will work in collaboration with SEED to mentor innovators and provide guidance to help them de-risk the technical and business elements of their product development projects. EIRs will also help NIH and individual innovators ensure the long-term success of their projects by facilitating connections with investors and strategic partners who can help achieve commercial success and healthcare consumer access. To be successful in this role, entrepreneurial, commercial or product development experience in areas of social impact including wellness & prevention, healthcare access/community health and a wide network in social impact ventures is required.
This position is currently remote (with opportunity for future in-person activities) and part time (20 hrs/week with potential for expansion); occasional travel may be required (when conditions permit).
These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices. If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.
To sign-up for any of the EIR dates in 2022, please follow this link.
The University of Maryland Baltimore County has joined the highest ranks of research universities in the country, a milestone for the young school with a reputation for producing scientists and engineers of color.
The 55-year-old university in suburban Baltimore reached Research 1, or R1, status, a distinction for universities with very high research activity.
Image: Trevor Shepard, a chemistry major, works on a viscosity experiment at the University of Maryland Baltimore County in October 2020. (Michael Robinson Chavez/The Washington Post)
Rising to the Top: The Importance of Increasing Diversity in STEM Leadership
Join Young Women In Bio and Winward Academy for a special career panel to learn from the passionate journeys of incredible female leaders in successful science careers.
We'll celebrate the International Day of Women in Science with Dr. Leticia Ferri and Ms. Wendy Clemens of Bristol Myers Squibb, the global pharmaceutical company, and with Ms. Abigail Hata of Horizon Therapeutics.
We'll learn more about their personal journeys and tips for teens interested in science and STEM careers.
While COVID-19 infections rates are on a downturn, the viral threat is expected to become an endemic concern, which means at-home testing will remain a booming sector in the industry. With its newly authorized at-home antigen test, Rockville’s MaximBio expects to carve out a significant share of the market.
At the end of January, the U.S. Food and Drug Administration granted Emergency Use Authorization to MaximBio’s ClearDetect COVID-19 Antigen Home Test, which has been designed to be as user-friendly as possible. MaximBio Chief Operating Officer Jonathan Maa believes that the company’s ClearDetect test will differentiate itself from other tests on the market due to its simplicity and the strength of the company’s proven Lateral Flow Assay (LFA) technology. In an interview with BioBuzz, Maa said at-home testing is an urgent need in the United States and that need “will exist for some time.”
The Universities at Shady Grove (USG) – with nine partner universities offering a wide range of life-changing academic programs on one convenient campus in Montgomery County – has been an innovative model for higher education delivery since its inception in 2000.
After two decades of growth, evolution and success, it’s time for the USG community to now build on the solid foundation it has established by charting a solid course for “USG 2.0.” It’s time for us to develop our first-ever Strategic Plan, to help shape the future direction of a unique University System of Maryland institution that is the largest and most comprehensive of the state’s regional higher education centers.
New zoning measure spearheaded by Friedson will accelerate and streamline the regulatory process to develop and spur expansion of biohealth facilities in Montgomery County
On Wednesday, February 16 at 10:30 a.m. Councilmember Andrew Friedson and Montgomery County biohealth and economic development leaders will hold a press conference to reinforce Montgomery County’s commitment to innovation and the biohealth sector at United Therapeutics Corp. in Silver Spring.
Looking to make connections and identify partners in the life sciences industry? Use the Maryland Life Sciences Directory, a free tool for exploring more than 1,000 profiles of companies active in Maryland’s robust life science markets, including biotechnology, medical technology, pharmaceuticals, digital health, manufacturing, regulatory services, and related subsectors. Explore company profiles for an overview of business activities, products, and services, and to connect with potential partners.
Children’s National Hospital successfully performed the first-ever high-intensity focused ultrasound (HIFU) surgery on a pediatric patient with neurofibromatosis (NF). This is the youngest patient to undergo HIFU treatment in the world. The advancement of children’s medical devices in the U.S. continues to significantly lag behind adult devices. This is why this milestone marks a significant advance in making pediatric surgery more precise and less invasive.
In 2020, the failure rate of startups was around 90%. Research showed that 21.5% of startups failed in the first year, 30% in the second year, 50% in the fifth year, and 70% in their 10th year. Stats like these can make a startup founder or a venture capital investor feel like things are a bit bleak, but perhaps there is a better way.
Small businesses with NHGRI grants were instrumental in contributing to the completion of the human genome sequence, redefining the future of genomics.
When Kelvin Liu began his doctorate degree in biomedical engineering at Johns Hopkins University in 2004, he knew his resume was unusual. His previous work painted him as more of an inventor and entrepreneur than an academic. Even before starting his doctoral research, Liu already had two patents under his name. Now, he has eight. Less than two years after graduating with his Ph.D., he became CEO of Circulomics, a biotechnology startup in downtown Baltimore.
